Structures by: Supratman U.
Total: 9
3,5-Bis[(<i>E</i>)-2-chlorobenzylidene]-1-methylpiperidin-4-one
C20H17Cl2NO
Acta Crystallographica Section E (2015) 71, 12 1488-1492
a=7.540(3)Å b=10.623(4)Å c=21.119(7)Å
α=90° β=98.671(5)° γ=90°
3,5-Bis[(<i>E</i>)-3-hydroxybenzylidene]-1-methylpiperidin-4-one
C20H19NO3
Acta Crystallographica Section E (2015) 71, 12 1488-1492
a=7.4852(6)Å b=9.8588(9)Å c=11.6115(10)Å
α=111.7924(17)° β=96.7983(18)° γ=92.8848(17)°
8,14-secogammacera-7,14(27)-diene-3,21-dione
C27H32O9
Acta Crystallographica Section E (2009) 65, 4 o750
a=8.83260(10)Å b=12.8977(2)Å c=11.15550(10)Å
α=90.00° β=110.7770(10)° γ=90.00°
(20<i>S</i>)-24,25-Dihydroxy-20,24-epoxy-3,4-secodammar-4(28)-en-3-oic acid
C30H50O5
Acta Crystallographica Section E (2010) 66, 2 o416
a=7.73220(10)Å b=22.4976(4)Å c=31.6043(5)Å
α=90.00° β=90.00° γ=90.00°
8,14-Secogammacera-7,14(27)-diene-3,21-dione—–8,14-secogammacera-7,14-diene-\ 3,21-dione (1.5/0.5)
1.5(C30H46O4),0.5(C30H46O4)
Acta Crystallographica Section E (2009) 65, 6 o1448
a=8.4522(2)Å b=11.7144(2)Å c=14.1292(3)Å
α=107.4840(10)° β=90.2490(10)° γ=104.8710(10)°
8-[2,3-dihydroxy-3-methylbutyl]-7-methoxy-2<i>H</i>-1-benzopyran-2-one
C15H18O5
Acta Crystallographica Section E (2010) 66, 3 o620
a=5.8061(7)Å b=10.5146(13)Å c=11.4477(14)Å
α=90.00° β=91.547(2)° γ=90.00°
14-Hydroxy-8,14-secogammacera-7-ene-3,21-dione
C30H48O3
Acta Crystallographica Section E (2010) 66, 7 o1621
a=11.8841(11)Å b=14.8301(13)Å c=15.2755(13)Å
α=90.00° β=90.00° γ=90.00°
3-<i>epi</i>-Dammarenediol II 1.075 hydrate
C30H52O2,1.075(H2O)
Acta Crystallographica Section E (2012) 68, 11 o3089-o3090
a=19.9481(13)Å b=19.9481(13)Å c=7.3410(7)Å
α=90.00° β=90.00° γ=90.00°
(20<i>S</i>)-Dammar-24-ene-3β,20-diol
C30H52O2,H2O
Acta Crystallographica Section E (2012) 68, 9 o2712-o2713
a=19.92290(10)Å b=19.9229Å c=7.33020(10)Å
α=90.00° β=90.00° γ=90.00°